Home » Stocks » ALC

Alcon, Inc. (ALC)

Stock Price: $72.04 USD 1.58 (2.24%)
Updated Jul 28, 2021 4:00 PM EDT - Market closed
Market Cap 35.22B
Revenue (ttm) 6.92B
Net Income (ttm) -390.00M
Shares Out 489.90M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE 36.90
Dividend $0.11
Dividend Yield 0.16%
Trading Day July 28
Last Price $72.04
Previous Close $70.46
Change ($) 1.58
Change (%) 2.24%
Day's Open 70.72
Day's Range 70.68 - 72.25
Day's Volume 740,810
52-Week Range 54.43 - 76.42

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021

6 days ago - Business Wire

Reposition your portfolio for dividend yields, says Ariel's Bhansali

YouTube video

Rupal Bhansali, Ariel International Fund & Ariel Global Fund portfolio manager, discusses her approach to investing right now as well as her top picks for the second half of the year.

Other stocks mentioned: GE, GSK
4 weeks ago - CNBC Television

GENEVA--(BUSINESS WIRE)--Alcon Announces Executive Committee Changes

1 month ago - Business Wire

GENEVA--(BUSINESS WIRE)--Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021

1 month ago - Business Wire

GENEVA--(BUSINESS WIRE)--Alcon Reports First Quarter 2021 Results

2 months ago - Business Wire

GENEVA--(BUSINESS WIRE)--Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza

3 months ago - Business Wire

GENEVA--(BUSINESS WIRE)--Alcon shareholders approve all binding resolutions at the 2021 Annual General Meeting

3 months ago - Business Wire

GENEVA--(BUSINESS WIRE)--Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.

3 months ago - Business Wire

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Alcon, Semtech, Upstart, and others.

Other stocks mentioned: ALXO, CURI, SMTC, UPST
4 months ago - CNBC

Alcon (NYSE:ALC) has observed the following analyst ratings within the last quarter:   Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 1 0 0 Somewhat Bullish 0 2 0 0 Indifferent 0 0 0 0 Som...

4 months ago - Benzinga

GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for Annual General Meeting

4 months ago - Business Wire

GENEVA--(BUSINESS WIRE)--Alcon to Host Virtual Capital Markets Day on March 24

4 months ago - Business Wire

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon's Sue-Jean Lin Wins 2021 Dallas CIO of the Year

4 months ago - Business Wire

Shares of Alcon (NYSE:ALC) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 8.89% over the past year to $0.41, which were in line w...

5 months ago - Benzinga

GENEVA--(BUSINESS WIRE)--Alcon Reports Fourth Quarter and Full Year 2020 Results

5 months ago - Business Wire

Alcon, Inc. (ALC) Presents at JPMorgan Healthcare Conference - (Transcript)

6 months ago - Seeking Alpha

Eye-care devices market is an attractive end-market supported by secular growth trends such as aging population, increased myopia prevalence, and innovation in products leading to better outcomes for pa...

7 months ago - Seeking Alpha

Alcon, Inc. (ALC) CEO David Endicott on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Unable to provide full-year guidance due to difficult market conditions, Alcon CEO says

YouTube video

Alcon CEO David Endicott discusses the company's third-quarter earnings.

8 months ago - CNBC International TV

Shares of Alcon (NYSE:ALC) rose 2.73% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 15.22% year over year to $0.39, which beat the estimat...

8 months ago - Benzinga

Alcon Inc. (ALC) CEO David Endicott on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Alcon Inc. (ALC) CEO David Endicott on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Alcon, Inc. (ALC) CEO David Endicott on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

The switch will increase the availability of pain and allergy drugs from GlaxoSmithKline and Alcon.

Other stocks mentioned: GSK
1 year ago - The Motley Fool

About ALC

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR sur... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1945
CEO
David J. Endicott
Employees
23,000
Stock Exchange
NYSE
Ticker Symbol
ALC
Full Company Profile

Financial Performance

In 2020, Alcon's revenue was $6.83 billion, a decrease of -8.99% compared to the previous year's $7.51 billion. Losses were -$531.00 million, -19.05% less than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for Alcon is 77.58, which is an increase of 7.69% from the latest price.

Price Target
$77.58
(7.69% upside)